Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$311,770
-$74,550 QoQ
Shares Held
500
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#932
of 1,322 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Dempze Nancy E holds $4,425,685 across 2 Biotechnology names. REGN ranks #2 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,282 | $4,113,915 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
500 | $311,770 |
All Filings in REGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $311,770 | 500 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $386,320 | 500 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $540,309 | 700 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $393,589 | 700 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $420,000 | 800 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $532,753 | 840 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $683,836 | 960 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,009,190 | 960 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,156,133 | 1,100 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||